Recessively-acting choline transporter mutations associated with severe congenital myasthenia disrupt transporter surface trafficking in vitro and in vivo

JSON

Wang H, Salter S, Refai O, Hardy H, Sejersen T, Wright J, Zimmerman H, Weis J, Schara U, Russell M, Abdul-Rahman O, Chilton J, Blakely R, Baple E, Crosby A, Cirak S

Neuromuscular Disorders 27 (-) S220-S221 [2017-10-00; online 2017-10-00]

DOI 10.1016/j.nmd.2017.06.454

Crossref 10.1016/j.nmd.2017.06.454